Key result
The Notch pathway regulates cardiomyocyte, fibroblast, and cardiac progenitor cell activity and may serve as a molecular target for novel therapies in age-related cardiac disease.
Thorough investigation of the Notch system in the aging myocardium may lead to the identification of molecular targets for novel therapies for age-related cardiac disease.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for Notch modulation in cardiac aging; leaves open clinical translation pending targeted studies.
The knowledge of the cellular events occurring in the aging heart has dramatically expanded in the last decade and is expected to further grow in years to come. It is now clear that impaired function and loss of cardiomyocytes are major features of cardiac aging, but other events are likewise important. In particular, accumulating experimental evidence highlights the importance of fibroblast and cardiac progenitor cell (CPC) dysfunction. The Notch pathway regulates cardiomyocyte, fibroblast, and CPC activity and, thus, may be critically involved in heart disease associated with advanced age, especially heart failure. In a translational perspective, thorough investigation of the Notch system in the aging myocardium may lead to the identification of molecular targets for novel therapies for age-related cardiac disease.
No takes yet. Share an insight, caveat, or question.
Rizzo et al. (2017) conducted a review in Cardiac aging. Notch pathway was evaluated. The Notch pathway regulates cardiomyocyte, fibroblast, and cardiac progenitor cell activity and may serve as a molecular target for novel therapies in age-related cardiac disease.
Synapse has enriched 10 related papers. Consider them for comparative context: